Related references
Note: Only part of the references are listed.Role of Sirtuins in Tumor Angiogenesis
Lincy Edatt et al.
FRONTIERS IN ONCOLOGY (2020)
Glucose Metabolism on Tumor Plasticity, Diagnosis, and Treatment
Xiaoping Lin et al.
FRONTIERS IN ONCOLOGY (2020)
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma
Xiaoguang Wang et al.
PROTEIN & CELL (2020)
Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells
Marta Di Martile et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3β/Snail signals
Panpan An et al.
ONCOGENE (2020)
Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
Yang Gao et al.
NATURE CELL BIOLOGY (2020)
HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma
Ruixue Zhang et al.
CELL DEATH & DISEASE (2020)
HDAC3 Inhibition Upregulates PD-L1 Expression in B-Cell Lymphomas and Augments the Efficacy of Anti-PD-L1 Therapy
Siyu Deng et al.
MOLECULAR CANCER THERAPEUTICS (2019)
SIRT7-mediated ATM deacetylation is essential for its deactivation and DNA damage repair
Ming Tang et al.
SCIENCE ADVANCES (2019)
Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer
Ling-jiao Zou et al.
ACTA PHARMACOLOGICA SINICA (2019)
Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferase KAT6A
David J. Leaver et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
Tessa Knox et al.
SCIENTIFIC REPORTS (2019)
Glucose Metabolism Drives Histone Acetylation Landscape Transitions that Dictate Muscle Stem Cell Function
Nora Yucel et al.
CELL REPORTS (2019)
Functions and mechanisms of non-histone protein acetylation
Takeo Narita et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Acetylation of AGO2 promotes cancer progression by increasing oncogenic miR-19b biogenesis
Hailong Zhang et al.
ONCOGENE (2019)
Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics
Ibraheem Ali et al.
CHEMICAL REVIEWS (2018)
Histone H1 acetylation at lysine 85 regulates chromatin condensation and genome stability upon DNA damage
Yinglu Li et al.
NUCLEIC ACIDS RESEARCH (2018)
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Amila Suraweera et al.
FRONTIERS IN ONCOLOGY (2018)
Dynamic Acetylation of Phosphoenolpyruvate Carboxykinase Toggles Enzyme Activity between Gluconeogenic and Anaplerotic Reactions
Pedro Latorre-Muro et al.
MOLECULAR CELL (2018)
Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth
Jonathan B. Baell et al.
NATURE (2018)
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
Angela Nebbioso et al.
CLINICAL CANCER RESEARCH (2017)
Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism
Igor Hrgovic et al.
EXPERIMENTAL DERMATOLOGY (2017)
Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model
Giovanna Sociali et al.
FASEB JOURNAL (2017)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation
Yubin Lei et al.
MOLECULAR CANCER (2017)
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Loren M. Lasko et al.
NATURE (2017)
VEGF amplifies transcription through ETS1 acetylation to enable angiogenesis
Jiahuan Chen et al.
NATURE COMMUNICATIONS (2017)
HDAC10 promotes angiogenesis in endothelial cells through the PTPN22/ERK axis
Baoyu Duan et al.
ONCOTARGET (2017)
Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression
Jing Yang et al.
SCIENTIFIC REPORTS (2017)
Lysine Deacetylation by HDAC6 Regulates the Kinase Activity of AKT in Human Neural Progenitor Cells
Jonathan Iaconelli et al.
ACS CHEMICAL BIOLOGY (2017)
Sirtuin 6 regulates glucose-stimulated insulin secretion in mouse pancreatic beta cells
Xiwen Xiong et al.
DIABETOLOGIA (2016)
Protein acetylation in metabolism - metabolites and cofactors
Keir J. Menzies et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition
Z. Meng et al.
ONCOGENE (2016)
Lysines 3241 and 3260 of DNA-PKcs are important for genomic stability and radioresistance
Eiichiro Mori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
The world of protein acetylation
Adrian Drazic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2016)
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases
Roman P. Simon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions
Abhishek Bhardwaj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
KAT2A/KAT2B-targeted acetylome reveals a role for PLK4 acetylation in preventing centrosome amplification
Marjorie Fournier et al.
NATURE COMMUNICATIONS (2016)
HDAC10 promotes lung cancer proliferation via AKT phosphorylation
Yiwei Yang et al.
ONCOTARGET (2016)
Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression
Shang-Jui Wang et al.
CELL REPORTS (2016)
HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
Elizabeth E. Hull et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Nissim Hay
NATURE REVIEWS CANCER (2016)
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
Sarah Picaud et al.
CANCER RESEARCH (2015)
Acetyl Coenzyme A: A Central Metabolite and Second Messenger
Federico Pietrocola et al.
CELL METABOLISM (2015)
Acetyl-CoA and the regulation of metabolism: mechanisms and consequences
Lei Shi et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
A Novel Cell-Permeable, Selective, and Noncompetitive Inhibitor of KAT3 Histone Acetyltransferases from a Combined Molecular Pruning/Classical Isosterism Approach
Ciro Milite et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses
Ariane Hammitzsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance
Kenta Masui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay et al.
SEMINARS IN CANCER BIOLOGY (2015)
50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond
Eric Verdin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Protein post-translational modifications and regulation of pluripotency in human stem cells
Yu-Chieh Wang et al.
CELL RESEARCH (2014)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
The growing landscape of lysine acetylation links metabolism and cell signalling
Chunaram Choudhary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Reversible acetylation regulates vascular endothelial growth factor receptor-2 activity
Annalisa Zecchin et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2014)
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
Edward Seto et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales
Asmaa E. El-Kenawi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Histone Deacetylase (HDAC) Inhibitors with a Novel Connecting Unit Linker Region Reveal a Selectivity Profile for HDAC4 and HDAC5 with Improved Activity against Chemoresistant Cancer Cells
Linda Marek et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress
Nirmalya Sen et al.
MOLECULAR CELL (2013)
Mitogenic and Oncogenic Stimulation of K433 Acetylation Promotes PKM2 Protein Kinase Activity and Nuclear Localization
Lei Lv et al.
MOLECULAR CELL (2013)
HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy
Byram W. Bridle et al.
MOLECULAR THERAPY (2013)
Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
Loredana Santo et al.
BLOOD (2012)
FoxO1, the transcriptional chief of staff of energy metabolism
Stavroula Kousteni
BONE (2012)
Acetylation-Dependent Regulation of Skp2 Function
Hiroyuki Inuzuka et al.
CELL (2012)
Alcohol Metabolism
Arthur I. Cederbaum
CLINICS IN LIVER DISEASE (2012)
Histone Deacetylase 6 (HDAC6) Is an Essential Modifier of Glucocorticoid-Induced Hepatic Gluconeogenesis
Robin Winkler et al.
DIABETES (2012)
Multiple Site Acetylation of Rictor Stimulates Mammalian Target of Rapamycin Complex 2 (mTORC2)-dependent Phosphorylation of Akt Protein
Emily J. Glidden et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Mechanistic insights into the regulation of metabolic enzymes by acetylation
Yue Xiong et al.
JOURNAL OF CELL BIOLOGY (2012)
Histone deacetylase 5 regulates glucose uptake and insulin action in muscle cells
Suryaprakash Raichur et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models
Li Shen et al.
PLOS ONE (2012)
Regulation of RAS oncogenicity by acetylation
Moon Hee Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis
Pablo J. Fernandez-Marcos et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
A Hormone-Dependent Module Regulating Energy Balance
Biao Wang et al.
CELL (2011)
Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis
Maria M. Mihaylova et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin
David Kaluza et al.
EMBO JOURNAL (2011)
Mammalian Sirtuins and Energy Metabolism
Xiaoling Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
The role of histone deacetylase 7 (HDAC7) in cancer cell proliferation: regulation on c-Myc
Caihua Zhu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Acetylation Regulates Gluconeogenesis by Promoting PEPCK1 Degradation via Recruiting the UBR5 Ubiquitin Ligase
Wenqing Jiang et al.
MOLECULAR CELL (2011)
Acetylation Targets the M2 Isoform of Pyruvate Kinase for Degradation through Chaperone-Mediated Autophagy and Promotes Tumor Growth
Lei Lv et al.
MOLECULAR CELL (2011)
The Deacetylase SIRT1 Promotes Membrane Localization and Activation of Akt and PDK1 During Tumorigenesis and Cardiac Hypertrophy
Nagalingam R. Sundaresan et al.
SCIENCE SIGNALING (2011)
Regulation of intermediary metabolism by protein acetylation
Kun-Liang Guan et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
Erin M. Bowers et al.
CHEMISTRY & BIOLOGY (2010)
Nonhistone protein acetylation as cancer therapy targets
Brahma N. Singh et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Acetylation of Rb by PCAF is required for nuclear localization and keratinocyte differentiation
Adam Pickard et al.
JOURNAL OF CELL SCIENCE (2010)
SIRT2 regulates NF-κB-dependent gene expression through deacetylation of p65 Lys310
Karin M. Rothgiesser et al.
JOURNAL OF CELL SCIENCE (2010)
Genomic instability - an evolving hallmark of cancer
Simona Negrini et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining
Kyle M. Miller et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Acetylation of Metabolic Enzymes Coordinates Carbon Source Utilization and Metabolic Flux
Qijun Wang et al.
SCIENCE (2010)
Regulation of Cellular Metabolism by Protein Lysine Acetylation
Shimin Zhao et al.
SCIENCE (2010)
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury
A. Lanzillotta et al.
CELL DEATH & DISEASE (2010)
Histone H3-K56 acetylation is important for genomic stability in mammals
Jian Yuan et al.
CELL CYCLE (2009)
Glucose Metabolism as a Target of Histone Deacetylase Inhibitors
Suzanne E. Wardell et al.
MOLECULAR ENDOCRINOLOGY (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
VEGF stimulates HDAC7 phosphorylation and cytoplasmic accumulation modulating matrix metalloproteinase expression and angiogenesis
Chang Hoon Ha et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells
Anna Scuto et al.
BLOOD (2008)
PTEN acetylation modulates its interaction with PDZ domain
Tsuneo Ikenoue et al.
CANCER RESEARCH (2008)
Acetylation is indispensable for p53 activation
Yi Tang et al.
CELL (2008)
MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo
Marielle Fournel et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
S. Balasubramanian et al.
LEUKEMIA (2008)
Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis
Denis Mottet et al.
CIRCULATION RESEARCH (2007)
DNA damage-induced acetylation of lysine 3016 of ATM activates ATM kinase activity
Yingli Sun et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
New nomenclature for chromatin-modifying enzymes
C. David Allis et al.
CELL (2007)
Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1
Sharon Wong et al.
BIOCHEMICAL JOURNAL (2007)
SIRT1 controls endothelial angiogenic functions during vascular growth
Michael Potente et al.
GENES & DEVELOPMENT (2007)
Acetylation-dependent signal transduction for type I interferon receptor
Xiaoli Tang et al.
CELL (2007)
The role of histone deacetylases (HDACs) in human cancer
Santiago Ropero et al.
MOLECULAR ONCOLOGY (2007)
Acetylation of the p53 DNA-binding domain regulates apoptosis induction
Stephen M. Sykes et al.
MOLECULAR CELL (2006)
Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis
Yi Tang et al.
MOLECULAR CELL (2006)
Small-molecule inhibitors of histone acetyltransferase activity: Identification and biological properties
Antonello Mai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
NF-κB and the immune response
M. S. Hayden et al.
ONCOGENE (2006)
Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway
N. D. Perkins
ONCOGENE (2006)
Angiogenesis in cancer
Naoyo Nishida et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2006)
PCAF modulates PTEN activity
Koichi Okumura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Substrate and functional diversity of lysine acetylation revealed by a proteomics survey
Sung Chan Kim et al.
MOLECULAR CELL (2006)
GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1α
Caries Lerin et al.
CELL METABOLISM (2006)
Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589
DZ Qian et al.
CLINICAL CANCER RESEARCH (2006)
Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription
F Faiola et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM
YL Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization
M Potente et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation
H Matsuzaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1
SF El-Khamisy et al.
NATURE (2005)
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
JT Rodgers et al.
NATURE (2005)
The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60
JH Patel et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The two NF-κB activation pathways and their role in innate and adaptive immunity
G Bonizzi et al.
TRENDS IN IMMUNOLOGY (2004)
Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305
YH Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Histone deacetylase inhibitors in cancer treatment
DM Vigushin et al.
ANTI-CANCER DRUGS (2002)
Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases
NA Barlev et al.
MOLECULAR CELL (2001)
Negative control of p53 by Sir2α promotes cell survival under stress
JY Luo et al.
CELL (2001)
hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase
H Vaziri et al.
CELL (2001)
Duration of nuclear NF-κB action regulated by reversible acetylation
LF Chen et al.
SCIENCE (2001)
Acetylation control of the retinoblastoma tumour-suppressor protein
HM Chan et al.
NATURE CELL BIOLOGY (2001)
Share Paper
